Indivior Pharmaceuticals, Inc. Entity Number of Employees
Indivior Pharmaceuticals, Inc. (INDV) had Entity Number of Employees of 1.00 thousand employee as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Notes › Cover Page
dei:EntityNumberOfEmployees · last filed 2025-07-31
- 2025-06-30: Entity Number of Employees 1.00K employee.
| Period end | Entity Number of Employees |
|---|---|
| 2025-06-30 | 1.00K employee 10-Q · filed 2025-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |